T.K. Kuilya et al. / Tetrahedron xxx (2014) 1e14
11
4.12. (R)-10-((tert-Butyldimethylsilyl)oxy)-9-(((S)-2,2-di-
methyl-1,3-dioxolan-4-yl)methyl)decan-1-ol (38)
68.1, 65.1, 37.8, 35.5, 31.7, 30.0, 29.5, 29.2, 28.8, 28.6, 27.2, 26.9, 26.0,
26.0, 18.5, 18.4, ꢀ5.3 ppm; IR (neat) nmax 3313, 2929, 2856, 2117,
1251 cmꢀ1; HRMS (ESI) m/z calcd for C24H46O3SiNa [MþNa]þ
433.3114, found 433.3112.
To a solution of oxalyl chloride (0.66 mL, 7.6 mmol) in dry CH2Cl2
(20 mL) at ꢀ78 ꢁC, DMSO (1.15 mL, 16.2 mmol) was added slowly in
drop wise manner with constant stirring under argon atmosphere.
After 15 min, compound 37 (1.9 g, 5.07 mmol) dissolved in dry
CH2Cl2 (10 mL) was added to the reaction mixture. After 30 min of
stirring at ꢀ78 ꢁC, Et3N (3.54 mL, 25.35 mmol) was added and stirred
for another 30 min at same temperature. The reaction mixture was
then allowed to warm to room temperature slowly to get an alde-
hyde. To the crude aldehyde (confirmed through TLC) Ph3P]
CHCO2Et (3.53 g, 10.14 mmol) was added and stirred at ambient
temperature for 36 h. The reaction mixture was then quenched with
saturated aqueous solution of NH4Cl and the organic layers were
washed with water, brine, dried (Na2SO4), filtered, and concentrated
in vacuo. Purification by column chromatography (SiO2, 5% EtOAc/
4.14. (3R,5S)-3-(Dec-9-ynyl)-dihydro-5-(hydroxymethyl)fu-
ran-2(3H)-one (22)
The desilylated compound (578 mg, 96%) was synthesized from
silyl ether 24 (840 mg, 2.04 mmol) using TBAF (1M in THF, 2.45 mL,
2.45 mmol) in THF (6 mL) following the same procedure as de-
scribed before for the shorter homologue: Rf¼0.3 (20% EtOAc/
hexane); [
a
]
29 þ2.6 (c 1.0, CHCl3); 1H NMR (CDCl3, 500 MHz)
d 4.22
D
(m, 1H), 4.05 (m, 1H), 3.61 (m, 1H), 3.56e3.48 (m, 2H), 2.45 (br s,
1H), 2.17 (dt, J¼7.0, 2.3 Hz, 2H), 1.94 (m, 1H), 1.71e1.68 (m, 1H),
1.66e1.60 (m, 2H), 1.54e1.49 (m, 2H), 1.41e1.36 (m, 9H), 1.28 (m,
9H); 13C NMR (CDCl3, 75 MHz)
d 109.1, 84.8, 73.5, 69.9, 68.2, 65.4,
hexane) furnished corresponding a,b-unsaturated ester (1.99 g, 89%)
37.7, 35.3, 30.9, 29.9, 29.5, 29.1, 28.8, 28.5, 27.1, 27.0, 25.9, 18.4 ppm;
IR (neat) nmax 3434, 3309, 2927, 2115 cmꢀ1; HRMS (ESI) m/z calcd
for C18H32O3Na [MþNa]þ 319.2249, found 319.2251.
(mixture of cis/trans isomers) as a colorless liquid: Rf¼0.67 (10%
EtOAc/hexane). The major peaks in 1H NMR (CDCl3, 400 MHz)
d
6.98e6.91 (m, 1H), 5.82e5.78 (d, J¼15.6 Hz, 1H), 4.20e4.13 (m, 3H),
Following the same procedure as adopted for shorter homo-
logue, the corresponding ester (552 mg, 92%) was prepared from
4.04e4.01 (m, 1H), 3.55e3.45 (m, 3H), 2.21e2.15 (m, 2H), 1.55e1.54
(m, 3H), 1.46e1.43 (m, 2H), 1.39 (s, 3H), 1.34 (br s, 4H), 1.29e1.25 (m,
8H), 0.87 (s, 9H), 0.02 (s, 6H). The major signals 13C NMR (CDCl3,
the alkynyl alcohol (550 mg, 1.85 mmol) obtained from above step:
27
Rf¼0.5 (10% EtOAc/hexane); [
a
]
ꢀ2.7 (c 4.0, CHCl3); 1H NMR
D
100 MHz) d 166.9, 149.4, 121.4, 108.7, 74.8, 70.2, 65.1, 60.2, 37.8, 35.5,
(CDCl3, 500 MHz)
d
4.06e3.99 (m, 2H), 3.68 (s, 3H), 3.53e3.47 (m,
32.3, 31.7, 29.6, 28.1, 27.2, 26.7, 26.0, 26.0, 18.4, 14.4, ꢀ5.3 ppm;; IR
1H), 2.62e2.56 (m, 1H), 2.17 (dt, J¼7.0, 2.5 Hz, 2H), 1.93 (t, J¼2.4 Hz,
1H), 1.91e1.85 (m, 1H), 1.68e1.60 (m, 2H), 1.54e1.47 (m, 3H), 1.39
(m, 5H), 1.32 (s, 3H), 1.27 (m, 8H); 13C NMR (CDCl3, 125 MHz)
(neat) nmax 2929, 1722, 1255 cmꢀ1; HRMS (ESI) m/z calcd for
C
24H46O5Si Na [MþNa]þ 465.3012, found 465.3010.
Following the same procedure adopted in reduction of ester 31,
d
176.6, 109.0, 84.8, 74.4, 69.5, 68.2, 51.6, 42.3, 36.4, 33.2, 29.5, 29.4,
the saturated alcohol 38 (1.5 g, 90%) was prepared from the above
-unsaturated ester (1.83g, 4.13 mmol) as a colorless oil using LiCl
(1.3 g, 30.98 mmol) and NaBH4 (1.17 g, 30.98 mmol) in THF (100 mL)
29.1, 28.8, 28.6, 27.2, 27.1, 25.7, 18.5 ppm; IR (neat) nmax 3290, 2931,
2115, 1735 cmꢀ1; HRMS (ESI) m/z calcd for C19H32O4Na [MþNa]þ
347.2198, found 347.2195.
a,b
25
and MeOH (100 mL) in 48 h: Rf¼0.25 (10% EtOAc/hexane); [
a]
D
Following the same procedure as described for lactone 23, the
title compound 22 (171 mg, 88%) was prepared from the above
ester (250 mg, 0.77 mmol) using CSA (18 mg, 0.07 mmol) in MeOH
þ5.9 (c 2.3, CHCl3); 1H NMR (CDCl3, 500 MHz)
d 4.17 (m, 1H), 4.03
(m, 1H), 3.63 (t, J¼6.6 Hz, 2H), 3.53 (dd, J¼10.0, 3.6 Hz, 1H),
3.49e3.46 (m, 2H), 1.57e1.54 (m, 5H), 1.39 (s, 3H), 1.34 (s, 3H),
1.32e1.24 (m, 12H), 0.87 (s, 9H), 0.02 (s, 6H); 13C NMR (CDCl3,
(3 mL): Rf¼0.25 (30% EtOAc/hexane); [
a
]
27 þ13.9 (c 8.7, CHCl3); 1H
D
NMR (CDCl3, 500 MHz)
d
4.61e4.57 (m, 1H), 3.89e3.84 (m, 1H),
125 MHz)
d 108.6, 74.8, 70.2, 65.1, 63.2, 37.8, 35.5, 32.9, 31.7, 30.0,
3.66e3.62 (m, 1H), 2.73e2.67 (m, 1H), 2.51 (br s, 1H), 2.33e2.28 (m,
1H), 2.17 (dt, J¼7.0, 2.4 Hz, 2H), 2.04e1.97 (m, 1H), 1.94e1.93 (m,
1H), 1.86e1.74 (m, 1H), 1.54e1.49 (m, 2H), 1.47e1.37 (m, 5H), 1.30
29.6, 29.5, 27.2, 26.9, 26.0, 26.0 25.8, 18.4, ꢀ5.3; IR (neat) nmax 3407,
2929, 2856 cmꢀ1; HRMS (ESI) m/z calcd for C22H46O4SiNa [MþNa]þ
425.3063, found 425.3066.
(br s, 6H); 13C NMR (CDCl3, 100 MHz)
d 180.0, 84.8, 78.7, 68.2, 64.6,
39.7, 31.3, 29.7, 29.3, 29.0, 28.7, 28.5, 27.3, 18.4 ppm; IR (neat) nmax
4.13. ((R)-2-(((S)-2,2-Dimethyl-1,3-dioxolan-4-yl)methyl)do-
dec-11-ynyloxy)(tert-butyl)dimethylsilane(24)
3294, 3444, 2929, 2856, 2115, 1770 cmꢀ1; HRMS (ESI) m/z calcd for
C
15H24O3Na [MþNa]þ 275.1623, found 275.1625.
The corresponding iodide (1.72 g, 92%) was synthesized starting
from precursor alcohol 38 (1.47 g, 3.65 mmol) using Ph3P (1.34 g,
5.11 mmol), imidazole (500 mg, 7.3 mmol) in toluene (20 mL) fol-
lowing the same procedure as described for the shorter homologue
4.15. (3R,5S)-Dihydro-5-(hydroxymethyl)-3-(octadeca-9,11-
diynyl)furan-2(3H)-one (39)
27
1
above. Rf¼0.5 (5% EtOAc/hexane); [
a
]
þ4.0 (c 2.1, CHCl3); H NMR
To a degassed solution of 22 (25 mg, 0.1 mmol) in Et3N (0.5 mL)
under argon atmosphere CuBr (3 mg, 0.02 mmol) and NH2OH$HCl
(2 mg, 0.028 mmol) were added sequentially. Alkynyl bromide 19
(19 mg, 0.1 mmol) dissolved in degassed Et3N (1 mL) was added
drop wise to the reaction mixture and stirred for 12 h at room
temperature. The reaction was quenched with water and extracted
with Et2O (10 mL).The organic layer was washed with water, brine,
dried (Na2SO4), and concentrated in vacuo. Purification by column
chromatography (SiO2, 30% EtOAc/hexane) furnished the coupled
product 39 (26 mg, 72%) as a colorless liquid: Rf¼0.56 (30% EtOAc/
D
(CDCl3, 500 MHz)
d
4.16 (m, 1H), 4.03 (m, 1H), 3.53 (m, 1H),
3.49e3.46 (m, 2H), 3.18 (t, J¼7.0 Hz, 2H),1.84e1.78 (m, 2H),1.59e1.55
(m, 3H) (merged with H2O), 1.39e1.34 (m, 9H), 1.27 (m, 9H), 0.88 (s,
9H), 0.02 (s, 6H); 13C NMR (CDCl3, 125 MHz)
d 108.6, 74.8, 70.2, 65.1,
37.8, 35.5, 33.7, 31.7, 30.6, 30.0, 29.5, 28.6, 27.2, 26.9, 26.0, 26.0, 18.4,
7.3, ꢀ5.3 ppm; IR (neat) nmax 2927, 2854, 1251 cmꢀ1; HRMS (ESI) m/z
calcd for C22H45IO3SiNa [MþNa]þ 535.2080, found 535.2079.
The titled alkyne 24 (859 mg, 80%) was prepared from the above
iodide (1.35 g, 2.63 mmol) using TMS alkyne (0.5 mL, 3.42 mmol)
and nBuLi (2.5 M in hexane, 1.26 mL, 3.15 mmol) in THF (10 mL) and
HMPA (2 mL) solvent system following the same procedure as
hexane); [
a
]
27 þ10.8 (c 1.6, CHCl3); 1H NMR (CDCl3, 500 MHz)
d 4.58
D
(m, 1H), 3.87 (dd, J¼12.3, 2.8 Hz, 1H), 3.65 (dd, J¼12.3, 4.7 Hz, 1H),
2.70 (m, 1H), 2.30 (m, 1H), 2.24 (t, J¼6.9 Hz, 4H), 2.00 (m, 1H), 1.80
(m, 1H), 1.53e1.48 (m, 4H), 1.38 (br s, 7H), 1.29 (br s, 10H), 0.88 (t,
describe for compound 25: Rf¼0.50 (5% EtOAc/hexane); [
a
]
27 þ8.2
D
(c 3.3, CHCl3); 1H NMR (CDCl3, 500 MHz)
d
4.17 (m, 1H), 4.02 (m,
1H), 3.54 (m, 1H), 3.50e3.46 (m, 2H), 2.17 (dt, J¼7.1, 2.3 Hz, 2H), 1.92
J¼6.9 Hz, 3H); 13C NMR (CDCl3, 125 MHz)
d 179.8, 78.6, 77.7, 77.6,
(m, 1H), 1.55e1.48 (m, 5H), 1.39e1.34 (m, 9H), 1.26 (br, 9H), 0.87 (s,
65.4, 65.3, 64.7, 39.7, 31.4, 31.3, 29.7, 29.3, 29.0, 28.8, 28.6, 28.4, 28.4,
9H), 0.02 (s, 6H); 13C NMR (CDCl3, 125 MHz)
d
108.6, 84.9, 74.8, 70.2,
27.3, 22.6, 19.3, 19.3, 14.1 ppm; IR (neat) nmax 3444, 2929, 2254,